Search for 'an:"1474" and au:Hitt Sabag, Ricardo'

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

By Brandariz Castelo, José Antonio | Hitt Sabag, Ricardo. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO, 2014 . 25(1):216–225. , Formato Vancouver: Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen A et al. Spanish Head and Neck Cancer Cooperative Group (TTCC). A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann Oncol. 2014 Jan;25(1):216-25.

Place Hold on A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

By Cortés-Funes Castro, Hernán | Hitt Sabag, Ricardo. Annals of Oncology, 2012 . 23(4):1016-22. , Formato Vancouver: Hitt R, Irigoyen A, Cortés-Funes H, Grau JJ, García-Sáenz JA, Cruz-Hernández JJ, et al. Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Ann Oncol. 2012 Apr;23(4):1016-22.

Place Hold on Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Tumores localmente avanzados de cabeza y cuello: enfermedad irresecable

By Hitt Sabag, Ricardo. . p. 39-40. , Formato Vancouver: Hitt Sabag R. Tumores localmente avanzados de cabeza y cuello: enfermedad irresecable. En: Sociedad Española de Oncología Médica. Ponencias X Congreso Nacional SEOM: 23 al 25 de junio de 2005, Zaragoza, Auditorio-Palacio de Congresos. Zaragoza: SEOM; 2005. p. 39-40

Place Hold on Tumores localmente avanzados de cabeza y cuello: enfermedad irresecable

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

By Hitt Sabag, Ricardo. Annals of Oncology, 2011 . 22(5):1078-1087. , Formato Vancouver: Licitra L, Mesia R, Rivera F, Remenár E, Hitt R, Erfán J, et al. Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study. Ann Oncol. 2011;22(5):1078-87.

Place Hold on Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

By Hitt Sabag, Ricardo. British Journal of Cancer, 2011 . 105(5):618-627. , Formato Vancouver: Del Campo JM, Hitt R, Sebastian P, Carracedo C, Lokanatha D, Bourhis J, et al. Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. Br J Cancer. 2011;105(5):618-27.

Place Hold on Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

Update on the diagnosis of cancer of unknown primary (CUP) origin

By Hitt Sabag, Ricardo | Homet, Blanca. Clinical and Translational Oncology, 2011 . 13(7):434-441. , Formato Vancouver: Ariza A, Balañá C, Concha Á, Hitt R, Homet B, Matilla A, Alba E. Update on the diagnosis of cancer of unknown primary (CUP) origin. Clin Transl Oncol. 2011Jul;13(7):434-41.

Place Hold on Update on the diagnosis of cancer of unknown primary (CUP) origin

Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors

By Castellano, Daniel | Hitt Sabag, Ricardo | Ciruelos Gil, Eva María | Cortés-Funes Castro, Hernán | Hitt Sabag, Ricardo | Colomer, R.. Annals of Oncology, 2003 . 14(5):783-787 , Formato Vancouver: Castellano D, Hitt R, Ciruelos E, Cortés-Funes H, Colomer R. Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors. Ann Oncol. 2003 May;14(5):783-7.

Place Hold on Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors